Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication

Immunology Letters

Volumn 117, Issue 2, 2008, Pages 161-167

  Rasool, Sahibzada T ^a   Tang, Heng ^b   Wu, Jianmei ^c   Li, Wei ^a   Mukhtar, Muhammad Mahmood ^a   Zhang, Jingwen ^a   Mu, Yongxin ^a   Xing, Huang Xioa ^a   Wu, Jianguo ^a   Zhu, Ying ^a  

^a School of Pharmaceutical Sciences   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Wuhan Blood Centre   (China)

Author keywords

HIV; Interleukin 32; siRNA

Indexed keywords

ANTIGEN P24; CYTOKINE; INTERLEUKIN 32; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS REPLICATION;

CELL LINE; CLONING, MOLECULAR; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION REGULATION; HIV; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HUMANS; INTERLEUKINS; RECOMBINANT PROTEINS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; VIRUS REPLICATION;

EID: 41449112756     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.01.007     Document Type: Article

References (20)

1. Kedzierska K., and Crowe S.M. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 12 (2001) 133-150
2. Graziosi C., Gantt K.R., Vaccarezza M., Demarest J.F., Daucher M., Saag M.S., et al. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Nat Acad Sci USA 93 (1996) 4386-4391
3. Rinaldo Jr. C.R., Armstrong J.A., Kingsley L.A., Zhou S., and Ho M. Relation of alpha and gamma interferon levels to development of AIDS in homosexual men. J Exp Pathol 5 (1990) 127-132
4. Birx D.L., Redfield R.R., Tencer K., Fowler A., Burke D.S., and Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 76 (1990) 2303-2310
5. Kundu M., and Basu J. IL-32: an emerging player in the immune response network against tuberculosis?. PLoS Med 3 (2006) e274
6. Schwartz S.A., and Nair M.P. Current concepts in human immunodeficiency virus infection and AIDS. Clin Diag Lab Immunol 6 (1999) 295-305
7. Netea M.G., Azam T., Ferwerda G., Girardin S.E., Walsh M., Park J.S., et al. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Nat Acad Sci USA 102 (2005) 16309-16314
8. Shoda H., Fujio K., Yamaguchi Y., Okamoto A., Sawada T., Kochi Y., et al. Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthr Res Ther 8 (2006) R166
9. Kim S.H., Han S.Y., Azam T., Yoon D.Y., and Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22 (2005) 131-142
10. Joosten L.A., Netea M.G., Kim S.H., Yoon D.Y., Oppers-Walgreen B., Radstake T.R., et al. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Nat Acad Sci USA 103 (2006) 3298-3303
11. Novick D., Rubinstein M., Azam T., Rabinkov A., Dinarello C.A., and Kim S.H. Proteinase 3 is an IL-32 binding protein. Proc Nat Acad Sci USA 103 (2006) 3316-3321
12. Netea M.G., Azam T., Lewis E.C., Joosten L.A., Wang M., Langenberg D., et al. Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med 3 (2006) e277
13. Zhang T., Li Y., Wang Y.J., Wang X., Young M., Douglas S.D., et al. Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells. Antivir Res 73 (2007) 132-139
14. Oliva A., Kinter A.L., Vaccarezza M., Rubbert A., Catanzaro A., Moir S., et al. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J Clin Invest 102 (1998) 223-231
15. Hexin Chen J.H., Fong S., Wilcox G., and Charles W. Jembrana disease virus tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for hiv tat in viral replication. J Virol 74 (2000) 11
16. Nobile C., Petit C., Moris A., Skrabal K., Abastado J.P., Mammano F., et al. Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes. J Virol 79 (2005) 5386-5399
17. Tal Ilani D.B.-S., Strous R.D., Mazor M., Sheinkman A., Kotler M., and Sara F. A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. PNAS 98 (2001) 625-628
18. Goda C., Kanaji T., Kanaji S., Tanaka G., Arima K., Ohno S., et al. Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 18 (2006) 233-240
19. Dahl C.A., Schall R.P., He H.L., and Cairns J.S. Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 148 (1992) 597-603
20. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur J Biochem/FEBS 270 (2003) 2109-2119